MedTrace Logo

EEG/ERP Longitudinal Study in Alzheimer's Disease (AD)

NCT02769234 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2020-02-26

No results posted yet for this study

Summary

In a previous study, NCT00582127, two age-matched cohorts, one clinically diagnosed with mild Alzheimer's disease and the other healthy controls, were tested with a hand-held EEG/ERP system to determine if the cohorts could be discriminated using the EEG/ERP measures. This study proposes to retest the AD cohort 18-60 months after their first test to characterize the change in EEG/ERP measures correlated with the longitudinal change in neuropsychological testing.

Conditions

Interventions

PROCEDURE

ERP/EEG test

The testing protocol consists of an auditory oddball ERP paradigm, followed by the collection of 3min of resting EEG. During the ERP paradigm a variety of auditory stimuli are played through the system's earphones while voltage potentials are recorded from the subject's scalp. At the end of the ERP session, 3 minutes of EEG data will be recorded while the subject is resting. The entire procedure, including set up, instructions to the subject and actual test is expected to take 45-60 minutes.

PROCEDURE

Psychometric testing

Subjects that complete ERP/qEEG testing successfully will move on to clinical and neuropsychological evaluation. Demographic information with also be collected.

Sponsors & Collaborators

  • Boston Center for Memory

    collaborator UNKNOWN

  • The Memory Clinic of Vermont

    collaborator UNKNOWN

  • Premiere Research Institute

    collaborator OTHER

  • Neuronetrix, Inc.

    lead INDUSTRY

Principal Investigators

  • Marco Cecchi, PhD · Neuronetrix, Inc.

Eligibility

Min Age
60 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-06-30
Completion
2017-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02769234 on ClinicalTrials.gov